Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

7.050 -1.500 (-17.54%)
Streaming Delayed Price Updated: 1:07 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bionano Genomics Inc

< Previous 1 2 3 4 5 Next >
Thinking about buying stock in Nio, Zomedica, Transenterix, Aileron Therapeutics, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for NIO, ZOM, TRXC, ALRN, and BNGO. 
From PR Newswire
COVID-19 Host Genome SV Consortium Identifies Structural Variants with Possible Roles in Pathogenesis and Outcomes in Severely Ill COVID-19 Patients Using Bionano’s Saphyr® System
First publication from international consortium highlights prowess of Saphyr in identifying large SVs with clinical significance and in COVID-19, an area with great public health implications 
From GlobeNewswire News Releases
Bionano Genomics Announces the Kick-Off of its Next-Generation Cytogenomics Symposium, The Largest Event Yet to Showcase Saphyr’s Utility in Genome Analysis for Genetic Disease and Cancer
From GlobeNewswire News Releases
Bionano Genomics Announces Pricing of $88.5 Million Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Thinking about buying stock in Sundial Growers, Zomedica, BioNano Genomics, IsoRay, or Jaguar Health?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, ZOM, BNGO, ISR, and JAGX. 
From PR Newswire
Thinking about buying stock in Sundial Growers, BioNano Genomics, Zomedica, Jaguar Health, or Onconova Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, BNGO, ZOM, JAGX, and ONTX. 
From PR Newswire
Small Cap Momentum Stocks on the Radar (NASDAQ: BNGO) (OTC US: MMEDF) (OTC US: LVGI) (OTC US: HVBTF)
Tags Crytocurrency biotechnology Cryptocurrency
From OTC
Thinking about buying stock in BioNano Genomics, Ocugen, Acasti Pharma, Novan, or Transenterix?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, ACST, NOVN, and TRXC. 
From PR Newswire
Thinking about buying stock in Ocugen, BioNano Genomics, FLIR Systems, Clearside Biomedical, or Viewray?
InvestorsObserver issues critical PriceWatch Alerts for OCGN, BNGO, FLIR, CLSD, and VRAY. 
From PR Newswire
Bionano Genomics Publishes Study on Autism Risk Genes After Detailed Analysis of The Genome of Professor Temple Grandin, Who Has Brought Awareness to Autism Spectrum Disorder Through Her Activism
From GlobeNewswire News Releases
Thinking about buying stock in BioNano Genomics, Ampio Pharmaceuticals, TRACON Pharmaceuticals, eMagin Corp, or Matinas BioPharma?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, AMPE, TCON, EMAN, and MTNB. 
From PR Newswire
Thinking about buying stock in Hepion Pharmaceuticals, BioNano Genomics, T2 Biosystems, Surface Oncology, or Sesen Bio?
InvestorsObserver issues critical PriceWatch Alerts for HEPA, BNGO, TTOO, SURF, and SESN. 
From PR Newswire
Bionano Genomics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
From GlobeNewswire News Releases
Thinking about buying stock in BioNano Genomics, Ocugen Inc, Biolase, Gevo, or FuelCell Energy?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, BIOL, GEVO, and FCEL. 
From PR Newswire
Thinking about buying stock in Zomedica, Jaguar Health, BioNano Genomics, Biolase, or Delta Air Lines?
InvestorsObserver issues critical PriceWatch Alerts for ZOM, JAGX, BNGO, BIOL, and DAL. 
From PR Newswire
Bionano Customer Praxis Genomics Accredited by College of American Pathologists, Completing First LDT in US for Constitutional Genetic Disorders that Uses Whole Genome Analysis with Saphyr as Alternat
From GlobeNewswire News Releases
Publication Reveals in Side-by-Side Comparison that Method Using PacBio Sequencing Detects Only 72% of the Large Structural Variants Detected by Optical Genome Mapping with Saphyr
From GlobeNewswire News Releases
Bionano Genomics Achieves Key Milestone with Software Update for its Saphyr System that Increases Throughput to 96 Human Genomes Per Week and Adds Saphyr Assure for Monitoring System Health
From GlobeNewswire News Releases
Bionano’s Saphyr System Used to Characterize Virus Integration Into Human Genome
From GlobeNewswire News Releases
Bionano Genomics Users Present the Saphyr System As a Novel Diagnostic Tool for Hematological Malignancies at ASH 2020
From GlobeNewswire News Releases
Bionano Genomics and its Users Present the Saphyr System for Optical Genome Mapping and Various Advancements in Clinical Variant Detection at AMP 2020
From GlobeNewswire News Releases
Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update
Company to host conference call today, November 12, at 4:30 pm ET 
From GlobeNewswire News Releases
Multi-Center Evaluation of Bionano Optical Genome Mapping by Cytogenetics Thought Leaders in the US Leads to Recommendation for Bionano’s Saphyr to Replace Karyotyping as First-Line Test for Detection
From GlobeNewswire News Releases
Largest Study To-Date Focused on Undiagnosed Genetic Disease Patients Reveals That Bionano’s Optical Genome Mapping Technology Can Diagnose Significantly More Patients Than Standard of Care Methods Al
Publication from UCSF shows Bionano’s optical genome mapping technology can detect pathogenic variants missed by whole exome sequencing and by chromosomal microarray in patients with rare genetic... 
From GlobeNewswire News Releases
Prowess of Bionano Genomics’ Saphyr System in Uncovering Novel Genetic Variations That Cause Cancer and Genetic Disease in Full Display at ASHG 2020
Top researchers present discoveries in cancer predisposition, neurodegenerative diseases, microdeletion syndromes and other genetic disorders made using Bionano’s optical genome mapping technology 
From GlobeNewswire News Releases
Rockefeller University Scientist Uses Bionano Saphyr to Analyze Genomes of Patients and Animals Susceptible to COVID-19
Using Bionano data in comparative genomics analysis of patients with severe disease and animals that are susceptible to SARS-CoV-2 against patients and animals resistant to disease may reveal... 
From GlobeNewswire News Releases
Bionano Genomics Releases Major Update to Its Suite of Software Tools That Simplifies Clinical Analysis, Reduces Time to Actionable Results and Makes Adoption by Clinical Labs Easier
Reduced compute time, faster variant analysis, more comprehensive clinical annotation and streamlined workflow for non-human model genomes used in drug development improve Saphyr’s best in class... 
From GlobeNewswire News Releases
Bionano Genomics' Saphyr System Shown to be Indispensable for the Analysis of Certain Genetic Disease Causing Variants
Recent publication shows Saphyr’s unique capability in resolving extremely complex structural variants that can cause common genetic disorders called microdeletion syndromes 
From GlobeNewswire News Releases
Bionano Genomics to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 12
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.